RANDAL J KIRK Insider Trading $ZIOP ZIOPHARM ONCOLOGY INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON).
RANDAL J KIRK in ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RANDAL J KIRK: Director
Holdings: 17,830,305 shares
Current Value: $119,463,044
Latest Transaction: Feb 10 2015
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in ZIOPHARM ONCOLOGY INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FCSC, GYHT, OGEN, XON, PRPO, SYN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | P | 8.75 | 1,440,000 | 12,600,000 | 17,830,305 | 16.4 M to 17.8 M (+8.79 %) |
| Nov 09 2012 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | P | 0.00 | 3,636,926 | 0 | 13,533,162 | 9.9 M to 13.5 M (+36.75 %) |
| Feb 07 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | P | 5.75 | 1,910,000 | 10,982,500 | 7,973,161 | 6.1 M to 8 M (+31.50 %) |
| Jan 14 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Option Exercise | A | 5.21 | 25,000 | 130,250 | 25,000 | |
| Jan 14 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | P | 0.00 | 3,636,926 | 0 | 6,063,161 | 2.4 M to 6.1 M (+149.90 %) |
| Jan 14 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Buy | P | 4.80 | 2,426,235 | 11,645,928 | 2,426,235 | 0 to 2.4 M |
| Jan 14 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Page: 1